Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

High-throughput proteogenomic expression screening of antimicrobial peptides within a single bioreactor

EF 2024-25

Résumé
Antimicrobial resistance is a major global health threat identified by the World Health Organization, emphasizing the urgent need for new treatments. Antimicrobial peptides (AMPs) are natural compounds found in nearly all organisms and are promising alternatives to current antibiotics due to their reduced susceptibility from antimicrobial resistance. Over 3,000 natural AMPs have been characterized, but their production on a scale suitable for human use poses significant challenges due to their diverse properties. This project aims to create a high-throughput method for efficiently screening the production of hundreds of AMPs using the non-pathogenic yeast Komagataella phaffi, currently used to produce various therapeutics and two food-grade recombinant proteins in Canada. The proposed method involves the parallel growth of hundreds of unique AMP expressing yeast strains under industrially accurate conditions. Secreted AMPs will be purified, and the quantity of different AMPs will be determined by tandem mass spectrometry methods. Highly expressed AMPs are expected to contain features that facilitate efficient secretion and resistance to chemical and enzymatic modifications. These features can be used to train machine learning models for which collaborators in this project have already developed, to create synthetic AMPs where bioactivity is considered in conjunction with ease of large-scale production. Methods and tools developed through the project are highly translatable and can be leveraged to rapidly optimize production of high value bioproducts and therapeutics in Komagataella phaffi. Discoveries from this project will be critical in Canada preparedness and agility in responding to emerging critical health threats.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529662
Name
Hong Oliver Y
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
High-throughput proteogenomic expression screening of antimicrobial peptides within a single bioreactor
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antimicrobial Peptide; Genomics; High-Throughput Screening; Komagataella Phaffi; Peptide Barcoding; Pichia Pastoris; Proteomics; Recombinant Protein; Strain Engineering; Tandem Mass Spectrometry
Abstract
Antimicrobial resistance is a major global health threat identified by the World Health Organization, emphasizing the urgent need for new treatments. Antimicrobial peptides (AMPs) are natural compounds found in nearly all organisms and are promising alternatives to current antibiotics due to their reduced susceptibility from antimicrobial resistance. Over 3,000 natural AMPs have been characterized, but their production on a scale suitable for human use poses significant challenges due to their diverse properties. This project aims to create a high-throughput method for efficiently screening the production of hundreds of AMPs using the non-pathogenic yeast Komagataella phaffi, currently used to produce various therapeutics and two food-grade recombinant proteins in Canada. The proposed method involves the parallel growth of hundreds of unique AMP expressing yeast strains under industrially accurate conditions. Secreted AMPs will be purified, and the quantity of different AMPs will be determined by tandem mass spectrometry methods. Highly expressed AMPs are expected to contain features that facilitate efficient secretion and resistance to chemical and enzymatic modifications. These features can be used to train machine learning models for which collaborators in this project have already developed, to create synthetic AMPs where bioactivity is considered in conjunction with ease of large-scale production. Methods and tools developed through the project are highly translatable and can be leveraged to rapidly optimize production of high value bioproducts and therapeutics in Komagataella phaffi. Discoveries from this project will be critical in Canada preparedness and agility in responding to emerging critical health threats.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hong, Oliver Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~